(Q39486499)

12 September 2017

title

Influence of the vascular damaging agents DMXAA and ZD6126 on hypericin distribution and accumulation in RIF-1 tumors (English)

1 reference

12 September 2017

Peter de Witte

4

0 references

author name string

Thierry Marysael

series ordinal

1

1 reference

12 September 2017

Yicheng Ni

series ordinal

2

1 reference

12 September 2017

Evelyne Lerut

series ordinal

3

1 reference

12 September 2017

language of work or name

1 reference

21 August 2011

1 reference

Journal of Cancer Research and Clinical Oncology

12 September 2017

published in

1 reference

12 September 2017

volume

137

1 reference

12 September 2017

issue

11

1 reference

12 September 2017

page(s)

1619-1627

1 reference

Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Non-invasive detection and quantification of acute myocardial infarction in rabbits using mono-[123I]iodohypericin microSPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Convection-enhanced delivery of 131I-chTNT-1/B mAB for treatment of high-grade adult gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Optimization of radioimmunotherapy of solid tumors: biological impediments and their modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

A dual-targeting anticancer approach: soil and seed principle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Disrupting established tumor blood vessels: an emerging therapeutic strategy for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Changes in mouse circulating leukocyte numbers in C57BL/6 mice immunosuppressed with dexamethasone for Cryptosporidium parvum oocyst production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Pharmacologic modulation of neutrophil functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Necrosis avid contrast agents: functional similarity versus structural diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Small-animal PET of tumor damage induced by photothermal ablation with 64Cu-bis-DOTA-hypericin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Disrupting tumour blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Elucidation of the tumoritropic principle of hypericin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Hypericin as a marker for determination of tissue viability after intratumoral ethanol injection in a murine liver tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Neutrophil influx and chemokine production during the early phases of the antitumor response to the vascular disrupting agent DMXAA (ASA404)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Morphological, functional and metabolic imaging biomarkers: assessment of vascular-disrupting effect on rodent liver tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1032-Y

Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response

21 January 2018

1 reference

12 December 2020

Immunogenicity of Iodine 131 chimeric tumor necrosis therapy monoclonal antibody in advanced lung cancer patients

1 reference

12 December 2020

Exploration of the mechanism underlying the tumor necrosis avidity of hypericin

1 reference

12 December 2020

Tumor necrosis treatment of ME-180 human cervical carcinoma model with 131I-labeled TNT-1 monoclonal antibody

1 reference

12 December 2020

Cell Death in Normal and Malignant Tissues

1 reference

12 December 2020

Discriminating vital tumor from necrotic tissue in human glioblastoma tissue samples by Raman spectroscopy

1 reference

12 December 2020

A novel method for the detection of necrotic lesions in human cancers.

1 reference

12 December 2020

Hypericin as a marker for determination of tissue viability after radiofrequency ablation in a murine liver tumor model.

1 reference

12 December 2020

10.1007/S00432-011-1032-Y

Identifiers

DOI

1 reference

12 September 2017

1 reference